To prevent an abnormal behavior occasionally occurring subsequent to the administration of an influenza treatment drug such as oseltamivir.
The agent of preventing abnormal behavior contains as an active ingredient at least one compound selected from the group consisting of acetazolamide, benzodiazepine compounds, valproic acid, phentramine, and fluoxetine. It is possible to effectively prevent abnormal behavior induced by the use of haloperidol and clonidine in combination and intensified by an influenza treatment drug. Therefore, it becomes possible to safely administer an influenza treatment drug such as oseltamivir to an influenza patient irrespectively of whether or not haloperidol and clonidine have already been administered to the patient or irrespectively of whether or not haloperidol and clonidine are to be administered to the patient.
USHIJIMA ITSUKO
Ogata Japanese
Yasuyuki Kurose
Next Patent: ENHANCED HERBICIDE AND METHOD OF APPLICATION THEREOF